VIC Team

VIC Team

Recent Posts

SFC Fluidics Inc. Receives $2 Million SBIR Grant to Develop Groundbreaking Dual Hormone System for Diabetes Care

Next Generation Closed Loop System Designed for Broader Type I Diabetes Patient Population Fayetteville, AR - SFC Fluidics Inc., a medical device company focusing on drug delivery for treatment of Type 1 Diabetes, is...

VIC 2023 Mid-Year Report

Despite the difficult fundraising environment currently existing nationwide, VIC’s portfolio of companies made impressive progress in the first half of 2023.

Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.

Solenic accelerates their mission to treat patients suffering from acute or chronic prosthetic joint infections (PJI). ADDISON, TEXAS – Solenic Medical, developer of a device that uses alternating magnetic fields (AMF)...

Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager

Thank you for taking the time to speak with us, Dr. Clark. Please tell us about your education and professional experience.

Nob Hill Therapeutics Selected for Featured Poster Presentation at Respiratory Innovation Summit

Albuquerque, NM, May 19, 2023 – Nob Hill Therapeutics (NHT), an inhalation technology company, today announced that it has been selected to be a featured poster presentation at the ATS 2023 Respiratory Innovation Summit...

VIC Foundry Awarded Phase I SBIR Grant from the National Institutes of Health

NIH Grant is to Develop a Portable Sample Preparation Device for Concentration and Recovery of Bacterial Contaminants

Cellia Science Awarded National Institutes of Health Phase I SBIR Funding

Fayetteville, AR - Cellia Science, a point-of-care hematology company, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Heart, Lung, and Blood...

VIC Fellows Spotlight: Matthew Leming, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

VIC 2022 Annual Report Executive Summary

2022 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Tech Adds Chantell Preston to Board of Directors

Bringing a proven track record in healthcare operations, innovation, and investing. FAYETTEVILLE, AR- VIC Technology Venture Development is pleased to announce the appointment of Chantell Preston, who brings 20+ years...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.